The first Ascendis Pharma A/S trade was made in Q2 2017.
Since then Jim Simons bought shares eight more times and sold shares on nine occasions. The investor sold all their shares in Q2 2026 and doesn't own any shares in Ascendis Pharma A/S anymore.
Avg closing price
Price range
Sold -117k shares
Q2 2026
Avg closing price
$233.68
Price range
$205.81
-
$266.72
New holding (+117k shares)
Q1 2026
Avg closing price
$227.71
Price range
$202.99
-
$242.09
Sold -82.7k shares
Q3 2023
Avg closing price
$93.55
Price range
$86.50
-
$103.97
New holding (+82.7k shares)
Q2 2023
Avg closing price
$87.03
Price range
$69.96
-
$97.84
Sold -55.1k shares
Q3 2020
Avg closing price
$143.74
Price range
$134.29
-
$154.32
Increased shares by 7.8% (+4k shares)
Q2 2020
Avg closing price
$137.30
Price range
$110.87
-
$156.01
Increased shares by 71.2% (+21.2k shares)
Q1 2020
Avg closing price
$129.93
Price range
$97.01
-
$145.11
Sold 60.0% shares (-44.8k shares)
Q4 2019
Avg closing price
$111.10
Price range
$91.45
-
$139.12
Sold 58.5% shares (-105k shares)
Q3 2019
Avg closing price
$111.55
Price range
$95.80
-
$118.90
Increased shares by 102.5% (+91k shares)
Q2 2019
Avg closing price
$119.66
Price range
$107.11
-
$132.09
New holding (+88.8k shares)
Q1 2019
Avg closing price
$87.57
Price range
$62.15
-
$129.99
Sold -41.9k shares
Q4 2018
Avg closing price
$62.83
Price range
$55.16
-
$69.67
Sold 25.8% shares (-14.6k shares)
Q3 2018
Avg closing price
$68.83
Price range
$63.77
-
$76.28
Increased shares by 750.9% (+49.9k shares)
Q2 2018